SEC Form 4 · accession 0001209191-15-084311
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Dec 8, 2015
Accepted (ET)
Dec 9, 2015 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Dec 8, 2015 | M | 33,211 | — | A | 218,884 | D | |
| Ordinary Shares | Dec 8, 2015 | F | 15,178 | $21.40 | D | 203,706 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Dec 8, 2015 | M | 33,211 | D | — | — | Ordinary Shares | 33,211 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 10,548 ordinary shares of the Issuer acquired by the reporting person on June 1, 2015 pursuant to an employee stock purchase program.
- F3On December 8, 2011, the reporting person was granted 132,842 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.